Back to results
US 2014/0212509 A1Published application
Inhibitors of poly(adp-ribose)polymerase
AssigneeAbbVie Inc.
InventorsVirajkumar B. Gandhi, Vincent L. Giranda, Jianchun Gong, Thomas D. Penning, Gui-Dong Zhu
Life of this patent
Estimating the term…
Abstract
Inhibitors of poly(ADP-ribose)polymerase, ways to make them and methods of treating patients using them are disclosed.
Claims4
1-46. (canceled)
A method of treating cancer in a mammal comprising administering thereto a therapeutically acceptable amount of a compound of selected from the group consisting of
- 4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)-5,6,7,8-tetrahydrophthalazin-1(2h)-one;
- 4-((2-fluoro-5-((4-oxo-3,4,5,6,7,8-hexahydrophthalazin-1-yl)methyl)phenyl)amino)-4-oxobutanoic acid;
- and
- 1-(2-fluoro-5-((4-oxo-3,4,5,6,7,8-hexahydrophthalazin-1-yl)methyl)phenyl)pyrrolidine-2,5-dione;
- or a pharmaceutically acceptable salt thereof.
2 more elements
Dependencies are inferred from the claim text.